| Dr Vidhya Murukesan, MB,BS | |
|
601 N 30th St, Creighton University - Gme, Omaha, NE 68131-2137 | |
| (402) 280-5250 | |
| Not Available |
| Full Name | Dr Vidhya Murukesan |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 22 Years |
| Location | 601 N 30th St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003047564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 5995 TEP (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - West Hospital | Cincinnati, OH | Hospital |
| Mercy Health - Clermont Hospital | Batavia, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clermont Internists Associates Inc | 6901885847 | 12 |
| Usacs Integrated Acute Care Services Of Ohio Llc | 9032527221 | 195 |
News Archive
BioTrends is pleased to announce the publication of the second wave of a syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis (RA). This report is the second in a three-wave series derived from on-line survey responses from 80 rheumatologists and qualitative interviews with 20 rheumatologists.
Senate Majority Leader Harry Reid continues to aim to get a health care reform bill to the floor next week, his spokeswoman said Friday, MarketWatch reports. "No date has been set to bring the bill to the floor for debate, she said, adding that Reid wants to bring it up 'as soon as we can.'"
The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 7 days ago
| Entity Name | Hospitalist Medicine Physicians Of Richland County, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639119027 PECOS PAC ID: 4284538430 Enrollment ID: O20031120000557 |
News Archive
BioTrends is pleased to announce the publication of the second wave of a syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis (RA). This report is the second in a three-wave series derived from on-line survey responses from 80 rheumatologists and qualitative interviews with 20 rheumatologists.
Senate Majority Leader Harry Reid continues to aim to get a health care reform bill to the floor next week, his spokeswoman said Friday, MarketWatch reports. "No date has been set to bring the bill to the floor for debate, she said, adding that Reid wants to bring it up 'as soon as we can.'"
The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 7 days ago
| Entity Name | Clermont Internists Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417059205 PECOS PAC ID: 6901885847 Enrollment ID: O20040715000402 |
News Archive
BioTrends is pleased to announce the publication of the second wave of a syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis (RA). This report is the second in a three-wave series derived from on-line survey responses from 80 rheumatologists and qualitative interviews with 20 rheumatologists.
Senate Majority Leader Harry Reid continues to aim to get a health care reform bill to the floor next week, his spokeswoman said Friday, MarketWatch reports. "No date has been set to bring the bill to the floor for debate, she said, adding that Reid wants to bring it up 'as soon as we can.'"
The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 7 days ago
| Entity Name | Hospitalist Medicine Physicians Of Ohio, Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043572290 PECOS PAC ID: 3779749197 Enrollment ID: O20120730000162 |
News Archive
BioTrends is pleased to announce the publication of the second wave of a syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis (RA). This report is the second in a three-wave series derived from on-line survey responses from 80 rheumatologists and qualitative interviews with 20 rheumatologists.
Senate Majority Leader Harry Reid continues to aim to get a health care reform bill to the floor next week, his spokeswoman said Friday, MarketWatch reports. "No date has been set to bring the bill to the floor for debate, she said, adding that Reid wants to bring it up 'as soon as we can.'"
The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 7 days ago
| Entity Name | Usacs Integrated Acute Care Services Of Ohio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043805690 PECOS PAC ID: 9032527221 Enrollment ID: O20210428002191 |
News Archive
BioTrends is pleased to announce the publication of the second wave of a syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis (RA). This report is the second in a three-wave series derived from on-line survey responses from 80 rheumatologists and qualitative interviews with 20 rheumatologists.
Senate Majority Leader Harry Reid continues to aim to get a health care reform bill to the floor next week, his spokeswoman said Friday, MarketWatch reports. "No date has been set to bring the bill to the floor for debate, she said, adding that Reid wants to bring it up 'as soon as we can.'"
The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vidhya Murukesan, MB,BS 601 N 30th St, Creighton University - Gme, Omaha, NE 68131-2137 Ph: (402) 280-5250 | Dr Vidhya Murukesan, MB,BS 601 N 30th St, Creighton University - Gme, Omaha, NE 68131-2137 Ph: (402) 280-5250 |
News Archive
BioTrends is pleased to announce the publication of the second wave of a syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis (RA). This report is the second in a three-wave series derived from on-line survey responses from 80 rheumatologists and qualitative interviews with 20 rheumatologists.
Senate Majority Leader Harry Reid continues to aim to get a health care reform bill to the floor next week, his spokeswoman said Friday, MarketWatch reports. "No date has been set to bring the bill to the floor for debate, she said, adding that Reid wants to bring it up 'as soon as we can.'"
The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 7 days ago
Dr. Marium Ilahi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Matthew John Kapalis, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |